Bjoern Chapuy

Employment

• Charité - Universitätsmedizin Berlin Professoor
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (114)

• A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.
  Blood 2026 DOI: 10.1182/blood.2025029329
  +Save
• Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.
  Oncologist 2026 DOI: 10.1093/oncolo/oyag132
  +Save
• Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis.
  Cell Reports 2026 DOI: 10.1016/j.celrep.2026.117652
  +Save
• Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.
  Blood 2026 DOI: 10.1182/blood.2026033320
  +Save
• Feasibility and safety of rapid glofitamab ramp-up.
  Leukemia 2026 DOI: 10.1038/s41375-026-03003-3
  +Save
• Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.
  Haematologica 2026 DOI: 10.3324/haematol.2025.300063
  +Save
• Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers.
  Blood Advances 2026 DOI: 10.1182/bloodadvances.2025017766
  +Save
• RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma.
  Proceedings of the National Academy of Sciences of the United States of Amerika 2026 DOI: 10.1073/pnas.2534531123
  +Save
• Clinical Predictors and Recurrence Characteristics Following Radiotherapy for Primary Central Nervous System Lymphoma: A Retrospective Cohort Study
  Cancers 2025 DOI: 10.3390/cancers17132176
  +Save
• Advancing personalized cancer therapy: Onko_DrugCombScreen-a novel Shiny app for precision drug combination screening.
  NAR Genomics and Bioinformatics 2025 DOI: 10.1093/nargab/lqaf004
  +Save